ABL Bio Inc. (KOSDAQ:298380)
106,300
-5,700 (-5.09%)
May 20, 2026, 3:30 PM KST
69.00% (1Y)
| Market Cap | 5.95T +78.5% |
| Revenue (ttm) | 79.35B +137.6% |
| Net Income | -37.81B |
| EPS | -734.08 |
| Shares Out | 55.99M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 453,937 |
| Average Volume | 690,993 |
| Open | 109,600 |
| Previous Close | 112,000 |
| Day's Range | 104,200 - 111,000 |
| 52-Week Range | 59,200 - 257,500 |
| Beta | 0.33 |
| RSI | 27.11 |
| Earnings Date | May 20, 2026 |